Spyre Therapeutics, Inc.
SYRE
35 insider filings · Latest: Oct 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Jul 3 1:33 AM | Sheldon SloanChief Medical Officer | Sale | 8,334 | $87.70 | $730.9K | 0(D) | View → |
| Jul 1, 2026 | Jul 3 1:32 AM | Cameron TurtleDirector, Chief Executive Officer | Sale | 15,000 | $87.69 | $1.3M | 582,540(D) | View → |
| Jul 1, 2026 | Jul 1 9:02 PM | CAMERON TURTLE | Proposed Sale | 45,000 | $88.78 | $4.0M | — | View → |
| Jun 25, 2026 | Jun 27 1:31 AM | Scott L BurrowsChief Financial Officer | Sale | 15,000 | $87.13 | $1.3M | 97,994(D) | View → |
| Jun 25, 2026 | Jun 25 8:03 PM | SCOTT BURROWS | Proposed Sale | 15,000 | $87.13 | $1.3M | — | View → |
| Jun 23, 2026 | Jun 24 1:57 AM | Fairmount Healthcare Fund II L.P. | Proposed Sale | 4,684,781 | $85.31 | $399.7M | — | View → |
| Jun 23, 2026 | Jun 24 1:56 AM | Fairmount Funds Management LLCDirector | Sale | 4,684,781 | $85.31 | $399.7M | 0(I) | View → |
| Jun 22, 2026 | Jun 24 1:32 AM | Michael Thomas HendersonDirector | Sale | 20,000 | $100.00 | $2.0M | 68,606(D) | View → |
| Jun 22, 2026 | Jun 22 8:44 PM | MICHAEL HENDERSON | Proposed Sale | 20,000 | $88.34 | $1.8M | — | View → |
| Jun 3, 2026 | Jun 4 1:32 AM | Sheldon SloanChief Medical Officer | Sale | 8,333 | $75.00 | $625.0K | 0(D) | View → |
| Jun 1, 2026 | Jun 4 1:31 AM | Cameron TurtleDirector, Chief Executive Officer | Sale | 15,000 | $70.43 | $1.1M | 597,540(D) | View → |
| Jun 1, 2026 | Jun 4 1:30 AM | Scott L BurrowsChief Financial Officer | Sale | 7,500 | $71.06 | $532.9K | 97,994(D) | View → |
| Jun 3, 2026 | Jun 3 8:27 PM | SHELDON SLOAN | Proposed Sale | 16,667 | $69.16 | $1.2M | — | View → |
| May 8, 2026 | May 9 1:31 AM | Michael Thomas HendersonDirector | Sale | 80,000 | $74.40 | $6.0M | 88,606(D) | View → |
| May 8, 2026 | May 8 8:22 PM | MICHAEL HENDERSON | Proposed Sale | 80,000 | $73.10 | $5.8M | — | View → |
| May 1, 2026 | May 2 1:35 AM | Scott L BurrowsChief Financial Officer | Sale | 12,500 | $71.37 | $892.1K | 97,994(D) | View → |
| May 1, 2026 | May 2 1:34 AM | Sheldon SloanChief Medical Officer | Sale | 78,333 | $71.50 | $5.6M | 0(D) | View → |
| May 1, 2026 | May 2 1:34 AM | Cameron TurtleDirector, Chief Executive Officer | Sale | 15,000 | $71.37 | $1.1M | 612,540(D) | View → |
| May 1, 2026 | May 1 8:44 PM | SHELDON SLOAN | Proposed Sale | 78,333 | $74.45 | $5.8M | — | View → |
| May 1, 2026 | May 1 8:44 PM | SCOTT BURROWS | Proposed Sale | 27,500 | $74.45 | $2.0M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | May 2 1:35 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 12,500 | $14.50 | 382,357(D) | View → |
| May 1, 2026 | May 2 1:34 AM | Sheldon SloanChief Medical Officer | Option Exercise | 78,333 | $27.46 | 321,667(D) | View → |
| Apr 1, 2026 | Apr 4 1:30 AM | Sheldon SloanChief Medical Officer | Option Exercise | 7,958 | $21.66 | 87,542(D) | View → |
| Apr 1, 2026 | Apr 4 1:29 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 7,500 | $14.50 | 394,857(D) | View → |
| Mar 3, 2026 | Mar 4 2:32 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 2,500 | $14.50 | 402,357(D) | View → |
← Previous
Page 2 of 2